Bovine Astrovirus: Veterinary Reference

Overview and Taxonomy of Bovine Astrovirus (BoAstV): Veterinary Reference

Discovery, Historical Context, and Initial Characterization

Bovine astrovirus (BoAstV) was first identified in 1978 in fecal samples collected from diarrheic calves in the United Kingdom, marking the initial recognition of astroviruses as potential enteric pathogens in cattle [1]. Since that seminal discovery, BoAstV has been documented in numerous countries across multiple continents, including Europe, Asia, the Americas, and Australia, underscoring its ubiquitous distribution in global bovine populations [1, 2]. The virus belongs to the family Astroviridae, a taxon of small, non-enveloped, single-stranded positive-sense RNA viruses that have historically been associated primarily with gastroenteritis in young animals and humans. However, the past decade has dramatically expanded our understanding of astrovirus tropism and pathogenic potential, particularly through the identification of neuroinvasive strains in both human and bovine hosts [1, 3]. This taxonomic and biological re-evaluation positions BoAstV as a pathogen of considerable veterinary and zoonotic concern, warranting detailed reference classification and epidemiological scrutiny under the frameworks of the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO), especially given the potential for cross-species transmission [1].

Taxonomic Classification and Genomic Architecture

BoAstV is classified within the genus Mamastrovirus of the family Astroviridae, which is further divided into two genera: Mamastrovirus (infecting mammals) and Avastrovirus (infecting birds) [1]. The genus Mamastrovirus encompasses a diverse array of species, with bovine astrovirus isolates currently not assigned a single unified species designation due to high genetic heterogeneity; rather, they are often grouped into genogroups based on phylogenetic analysis of the complete capsid protein (ORF2) and the RNA-dependent RNA polymerase (RdRp) encoded by ORF1b [1, 3]. The BoAstV virion is approximately 28–30 nm in diameter, exhibiting the characteristic star-like surface morphology that gives the family its name, though this feature is not always discernible by negative-stain electron microscopy [1].

The viral genome is a linear, positive-sense RNA molecule, typically 6.2–7.7 kb in length, and is organized into three canonical open reading frames (ORFs). ORF1a and ORF1b encode the non-structural polyproteins, including the serine protease and the RNA-dependent RNA polymerase, respectively, while ORF2 encodes the structural capsid protein precursor [1, 3]. A ribosomal frameshift mechanism between ORF1a and ORF1b, involving a conserved slippery sequence and an RNA pseudoknot, regulates the expression of the RdRp, a feature common to all astroviruses [1]. The 5′ and 3′ untranslated regions (UTRs) are short but contain essential cis-acting elements for genome replication and translation. The polyadenylated 3′ terminus is another hallmark of the family. Comprehensive genomic comparisons have revealed that BoAstV isolates exhibit substantial sequence divergence; for example, the neurotropic strain BoAstV-CH15 shares less than 65% nucleotide identity across its complete genome with previously characterized astrovirus isolates, placing it in a distinct phylogenetic cluster [3]. This degree of genetic diversity complicates taxonomic classification and necessitates a polythetic approach incorporating genome organization, sequence phylogeny, and host range.

Phylogenetic Diversity and the Emergence of Neurotropic Lineages

Phylogenetic analyses based on full-length ORF2 amino acid sequences have consistently distinguished two major clades among mammalian astroviruses: the “classical” enteric clade, which includes most bovine fecal isolates, and the “atypical” or “HMO” (human, mink, ovine) clade, which contains astroviruses associated with encephalitis in humans, mink, and cattle [1, 3]. Until recently, BoAstV was considered exclusively an enteric pathogen, but the discovery of neuroinvasive strains, BoAstV NeuroS1 in the United States and BoAstV-CH13 and BoAstV-CH15 in Switzerland, fundamentally altered the taxonomic landscape [1, 3]. BoAstV-CH15, identified in a 4-year-old Braunvieh cow presenting as a BSE suspect, was recovered from brain tissue (medulla oblongata) and was found to be phylogenetically nested within the HMO clade, clustering most closely with an ovine astrovirus (OvAstV) isolate rather than with classical bovine fecal astroviruses [3]. This finding demonstrates that the neurotropic phenotype in cattle is not restricted to a single viral lineage; indeed, BoAstV-CH13 and BoAstV-CH15 are only distantly related to each other, indicating that at least two independent astrovirus genotypes have acquired the ability to invade the central nervous system of bovines [3]. Sliding-window pairwise comparisons further confirmed that BoAstV-CH15 shares higher sequence identity with OvAstV than with BoAstV-CH13 or human encephalitis-associated astroviruses, suggesting possible cross-species transmission events between sheep and cattle or a common ancestral origin [3].

The taxonomic implications of these findings are profound. Current Mamastrovirus species demarcation criteria, which typically require amino acid identity thresholds in the capsid protein (e.g., less than 66% for new species), are challenged by the existence of these divergent neurotropic strains [1, 3]. Given that BoAstV-CH15 was detected in a single animal that also harbored BoAstV-CH13, dual infections with distinct neurotropic astrovirus genotypes occur in nature, adding further complexity to epidemiological investigations [3]. The World Organisation for Animal Health (WOAH) does not currently list BoAstV as a notifiable pathogen, but the recognition of its neurotropic potential and its phylogenetic relationship to human encephalitis-associated astroviruses argues for enhanced surveillance and standardized taxonomic reporting within the Mammalian Orthoreovirus and Astrovirus Reference Centres.

Epidemiology, Tissue Tropism, and Clinical Context

BoAstV exhibits an extraordinarily wide tissue tropism, having been detected in intestinal contents, nervous tissue, and respiratory tract samples, often in both healthy and clinically ill animals [1]. Metagenomic studies have consistently found BoAstV at high prevalence in fecal samples, including a recent cross-sectional analysis in Ubaté Province, Colombia, where BoAstV was identified in 19% of bovine fecal samples using Oxford Nanopore sequencing, ranking third in frequency after Enterovirus E (59%) and Bovine Kobuvirus (52%) [2]. Importantly, these data were derived from apparently healthy cattle, highlighting the high rate of subclinical infections. The pathogenic role of BoAstV remains controversial because it is frequently found in co-infections with other enteric and respiratory viruses, such as bovine coronavirus, bovine viral diarrhea virus, bovine rotavirus, and Escherichia coli, making it difficult to attribute clinical disease solely to astrovirus infection [1]. In diarrheic calves, BoAstV detection rates vary widely by geographic region and diagnostic methodology, ranging from single-digit percentages to over 30% [1]. Experimental animal models have not been described, and stable cell culture systems for BoAstV propagation are lacking, severely hindering Koch’s postulate fulfillment [1]. This gap is critical for veterinary reference purposes: without a reliable in vitro culture system to generate pure virus stocks, challenge studies in calves remain unfeasible, and the assessment of virulence determinants is limited to genomic inference [1].

The discovery of BoAstV CH13 and CH15 in cases of non-suppurative encephalomyelitis in cattle has provided the strongest evidence for a causal role in neurological disease. In a retrospective analysis of 22 Swiss cattle with unresolved encephalitis, BoAstV-CH13 was detected in 5 animals (23%), and BoAstV-CH15 in an additional 2 animals, including the BSE-suspect cow [3]. Histopathological examination revealed severe lymphohistiocytic inflammation in the brainstem, cerebellum, and spinal cord, consistent with viral encephalitis [3]. BoAstV RNA was localized by RT-PCR to multiple brain regions, including the medulla oblongata, cerebellar cortex, midbrain, and cerebral cortex, indicating widespread neuroinvasion [3]. These findings have been corroborated by independent detection of BoAstV NeuroS1 in the USA, confirming that at least two distinct clades of bovine astrovirus have acquired neurotropism [1, 3]. The epidemiological significance of these neurotropic strains is unknown, but their presence in asymptomatic animals suggests that BoAstV may persist in neural tissue without invariably causing clinical signs, analogous to the carrier state observed in human astrovirus encephalitis in immunocompromised patients.

Diagnostic Approaches and Implications for Taxonomy

The detection and classification of BoAstV have advanced significantly with the advent of viral metagenomics and next-generation sequencing. Methods such as unbiased metatranscriptomic sequencing and targeted amplicon sequencing (e.g., using 198 primers designed for 43 bovine pathogens) enable the simultaneous detection of BoAstV alongside other viral, bacterial, and parasitic agents [4]. However, the genetic diversity of BoAstV complicates molecular diagnostics; RT-PCR assays targeting conserved regions of ORF1b are widely used but may miss divergent strains such as BoAstV-CH15 if primers are designed against classical enteric isolates [1, 3]. The metagenomics proficiency testing conducted on porcine astrovirus models (which are directly relevant to bovine diagnostics) demonstrated that reference genome selection dramatically affects read classification and quantification, a lesson that applies equally to BoAstV detection in clinical specimens [5]. For veterinary reference laboratories, taxonomic classification of a novel BoAstV isolate should follow the International Committee on Taxonomy of Viruses (ICTV) guidelines, incorporating complete ORF2 sequencing and phylogenetic placement within the Mamastrovirus genus. The absence of a standardized reference strain for bovine astroviruses, given the existence of multiple genotypes (e.g., BoAstV-CH13, BoAstV-CH15, and classical enteric strains), demands that diagnostic reports specify the genogroup identified, particularly when assessing neurotropic potential [3].

Future efforts should prioritize the establishment of a unified BoAstV taxonomic framework that accommodates both enteric and neurotropic lineages, with formal species demarcation based on capsid amino acid identity and host association. Integration with global surveillance initiatives under the WOAH/FAO One Health umbrella will be essential for monitoring the zoonotic risk, as the HMO clade includes viruses capable of causing severe encephalitis in humans, and the detection of closely related bovine strains in neural tissue raises the specter of interspecies transmission [1, 3]. Until then, the veterinary community must consider BoAstV not as a single pathogen but as a diverse group of viruses with distinct ecologies, tissue tropisms, and pathogenic potentials, a nuance that is critical for accurate diagnosis, disease management, and biosecurity policy.

Molecular Pathogenesis and Tissue Tropism of Bovine Astrovirus

Introduction to Pathogenic Mechanisms

Bovine astrovirus (BoAstV) presents a unique and complex paradigm in veterinary virology, characterized by a remarkably broad tissue tropism that belies its simple, non-enveloped, single-stranded positive-sense RNA genome [1]. Unlike many enteric pathogens that have evolved a singular, highly specialized niche, BoAstV demonstrates a remarkable capacity to infect and induce pathology across multiple organ systems, including the gastrointestinal tract, the central nervous system (CNS), and the respiratory tract [1]. This section delves into the molecular intricacies that govern BoAstV pathogenesis and the determinants that facilitate such diverse tissue colonization. The pathogenic landscape of BoAstV is further complicated by its frequent detection in both clinically healthy and diseased animals, often in the context of co-infections with other viral or bacterial pathogens, making the definitive attribution of disease causality a persistent challenge [1]. The absence of stable, continuously passaged cell lines for in vitro propagation and the lack of robust, widely available animal models have historically constrained the depth of mechanistic inquiry into BoAstV pathogenesis, necessitating a reliance on metagenomic, phylogenetic, and histopathological data from field cases and retrospective studies [1, 3].

Molecular Mechanisms of Cellular Entry and Replication

The initial stages of BoAstV infection are governed by the interactions between the viral capsid protein, encoded by open reading frame 2 (ORF2), and host cell surface receptors. While the specific receptor(s) for BoAstV remain largely uncharacterized, astroviruses in general are known to utilize sialic acid-containing glycans and other surface molecules for attachment. The high genetic diversity in the capsid protein, particularly in the hypervariable regions, is a primary driver of antigenic variation and is likely a key determinant of the virus's tissue tropism. The capsid protein, once translated as a precursor, undergoes a series of proteolytic cleavages by extracellular host proteases (e.g., trypsin) that are essential for viral infectivity. These cleavages result in the formation of a mature, infectious virion and the release of a peptide that may contribute to the disruption of tight junctions in epithelial barriers, facilitating viral dissemination across mucosal surfaces. Following receptor-mediated endocytosis, the positive-sense RNA genome is released into the cytoplasm, where it serves directly as a template for the translation of the nonstructural polyproteins from ORF1a and ORF1b. A ribosomal frameshifting mechanism ensures the translation of the RNA-dependent RNA polymerase (RdRp), which then orchestrates the replication of viral RNA via a negative-sense intermediate. Replication occurs in association with membrane-bound structures, and the assembly of new virions is thought to take place in the cytoplasm, followed by non-lytic release via exocytosis, which allows for persistent infection without immediate cell destruction. This non-lytic mechanism is a critical feature, enabling BoAstV to establish subclinical or chronic infections while evading host immune detection for extended periods.

Molecular Basis of Neurotropism and Encephalitis

One of the most clinically significant facets of BoAstV pathogenesis is its ability to invade the central nervous system, causing non-suppurative encephalitis. The first description of neurotropic BoAstV isolates, such as BoAstV NeuroS1 and BoAstV-CH13, provided unequivocal evidence that astroviruses can be a primary cause of neurological disease in cattle, expanding the known pathogenic spectrum far beyond enteric disease [3]. The molecular determinants of neurotropism are believed to reside within the capsid protein, which facilitates entry across the blood-brain barrier (BBB) or via infection of peripheral nerves retrogradely transported to the CNS. The specific capsid domains conferring this neuroinvasive capacity are under active investigation, but it is hypothesized that specific amino acid residues or conformational motifs mediate high-affinity binding to receptors present on brain microvascular endothelial cells or neurons. The identification of a second, genetically distinct encephalitis-associated astrovirus, BoAstV-CH15, with less than 65% genetic similarity to BoAstV-CH13 in the capsid region, underscores that neurotropism is not a singular, conserved trait but has evolved independently in distinct BoAstV lineages [3]. Phylogenetic analyses firmly place these neurotropic bovine isolates within the HMO (human, mink, ovine) clade, a group of astroviruses with a demonstrated predilection for causing neurological infections in their respective hosts, including humans and mink. The pathology in the CNS is characterized by a severe, non-suppurative meningoencephalomyelitis with perivascular cuffing and gliosis, primarily in the brainstem and cerebellum, indicating a direct viral cytopathic effect and an accompanying robust inflammatory host response that may contribute to the neuronal damage [3]. The detection of viral RNA across multiple brain regions (medulla oblongata, cerebellar cortex, midbrain) confirms the widespread dissemination of the virus within the CNS once the BBB is breached [3].

Molecular Basis of Enteric Tropism and Systemic Dissemination

The historical and most consistently recognized form of BoAstV infection is enteric, with the virus first isolated from diarrheic calves in 1978 [1]. Replication within the intestinal epithelium is initiated by the attachment of the capsid to receptors on the apical surface of enterocytes, likely targeting the microvilli. The non-lytic release of virions is particularly advantageous in the gut, as it allows for high levels of virus shedding in feces without compromising the integrity of the epithelial barrier, a feature that contributes to efficient fecal-oral transmission and environmental contamination. The capsid's resistance to the acidic and proteolytic environment of the stomach and gastrointestinal tract is a crucial adaptation for enteric survival. Once inside the enterocyte, replication proceeds as described, leading to the production of progeny virions that can either be shed into the lumen or disseminate basolaterally into the lamina propria. This basolateral spread is the critical gateway to systemic infection, providing the virus access to the lymphatic and circulatory systems, which then serve as conduits to secondary sites of replication, most notably the respiratory tract and the CNS. The detection of BoAstV in the respiratory tract further complicates the pathogenesis, suggesting that the virus may utilize a fecal-oral and potentially a respiratory route for transmission, or that respiratory involvement is a manifestation of systemic infection [1]. Metagenomic studies consistently report the presence of BoAstV in fecal samples from both diarrheic and non-diarrheic cattle, often at a high prevalence (e.g., 19% in a Colombian study), confirming that enteric infection can result in a healthy carrier state alongside its role in enteric disease [2].

The Conundrum of Subclinical Infection and Co-infection

A major impediment to a clear understanding of BoAstV pathogenesis is its high prevalence in clinically healthy animals and its frequent association with co-infections [1]. This has led to a significant debate regarding whether BoAstV is a primary pathogen or an opportunistic agent that exacerbates the pathogenicity of other viruses. The ability of BoAstV to establish persistent, subclinical infections in the gut is likely an evolutionary strategy for maximizing transmission, as asymptomatic animals can shed large quantities of virus over extended periods. The detection of BoAstV alongside other enteric pathogens like Enterovirus E and Bovine Kobuvirus [2], or in cases of BRD alongside bacterial agents like Mycoplasma and Pasteurellaceae [6], suggests a synergistic or polymicrobial disease complex. In such scenarios, BoAstV infection may cause subtle damage to the epithelial barrier, increasing permeability and facilitating the translocation of secondary pathogens. Alternatively, the immunosuppressive effects of a concurrent viral infection could reactivate a latent or persistent BoAstV infection, leading to disease. This inability to perform simple Koch's postulate-based experiments due to the lack of a permissive cell culture system and animal models remains the single most significant barrier to resolving the true pathogenic role of BoAstV in many of the clinical syndromes with which it is associated [1]. The advent of unbiased metagenomic sequencing has been instrumental in uncovering the diversity of BoAstV and its presence in various tissues, but it has also highlighted the need for functional studies to differentiate between viral presence and active, pathogenic replication [4, 5]. The clinical significance of BoAstV thus likely falls on a spectrum, ranging from an avirulent, commensal-like state in the gut of a healthy animal to a severe, neuroinvasive pathogen, and the factors, host genetic, immune status, viral genotype, and the composition of the resident microbiome, that determine the outcome of infection represent the central, unresolved questions in BoAstV molecular pathogenesis.

Epidemiology and Global Distribution of Bovine Astrovirus

Bovine astrovirus (BoAstV) represents a ubiquitous and genetically diverse pathogen of cattle, with a global distribution that has been increasingly elucidated through the application of advanced molecular diagnostic techniques, particularly viral metagenomics and next-generation sequencing. Since its initial identification in fecal samples from diarrheic calves in the United Kingdom in 1978 [1], BoAstV has been documented across a vast array of geographical regions, encompassing Europe, Asia, the Americas, and Oceania. The true prevalence and epidemiological significance of BoAstV, however, remain incompletely understood due to its frequent detection in both clinically affected and apparently healthy animals, its common occurrence as part of polymicrobial infections, and the historical lack of standardized, highly sensitive diagnostic assays [1]. The epidemiological landscape of BoAstV is further complicated by its remarkable tissue tropism, which extends beyond the classical enteric tract to include the nervous system and respiratory tract, suggesting a spectrum of potential disease associations that are only beginning to be explored [1, 3].

Prevalence in Healthy and Diarrheic Cattle Populations

The prevalence of BoAstV varies considerably depending on the geographic region, the age group of the cattle sampled, the clinical status of the animals, and the diagnostic methodology employed. Early studies, relying on electron microscopy and conventional reverse-transcription PCR (RT-PCR), often reported BoAstV in a modest proportion of diarrheic samples. However, the advent of metagenomic sequencing has revealed a much higher prevalence than previously appreciated, particularly in healthy cattle, which may serve as a significant reservoir for viral shedding. A comprehensive viral metagenomic study conducted in the Ubaté Province of central Colombia, a major dairy-producing region, detected BoAstV in 19% of fecal samples from cattle [2]. This study, which utilized Oxford Nanopore Technologies sequencing, also reported high frequencies of other enteric viruses, including Enterovirus E (59%) and Bovine Kobuvirus (52%), highlighting the complex viral communities present in bovine feces [2]. The detection of BoAstV in Colombia was a first for the country, underscoring the utility of metagenomic approaches for uncovering the true distribution of understudied pathogens in regions with limited prior surveillance [2].

The prevalence of BoAstV in healthy cattle is a critical epidemiological feature. The virus is frequently shed in the feces of asymptomatic animals, which can act as a continuous source of infection for susceptible cohorts, particularly young calves. This carrier state complicates the establishment of a direct causal link between BoAstV and enteric disease. In many studies, the prevalence of BoAstV in healthy control groups is comparable to, or even exceeds, that in diarrheic groups, suggesting that the virus may require co-factors, such as co-infection with other enteric pathogens (e.g., rotavirus, coronavirus, Escherichia coli K99, or Cryptosporidium parvum), immune status of the host, or specific viral genotypes, to induce clinical disease [1]. This phenomenon is not unique to BoAstV and is observed with other astroviruses in swine and humans, where the virus is considered a common commensal of the gut that can become pathogenic under certain conditions. The high prevalence in healthy animals also has significant implications for biosecurity and herd management, as subclinically infected animals can introduce and maintain the virus within a herd, making control strategies based solely on clinical signs ineffective.

Global Distribution and Regional Epidemiological Patterns

BoAstV has been reported on every continent where cattle are raised, demonstrating a truly global distribution. The virus was first discovered in the United Kingdom, and subsequent surveillance efforts have confirmed its presence throughout Europe, including Switzerland, France, and Ireland [1, 3]. In Switzerland, a seminal study utilizing unbiased next-generation sequencing identified BoAstV as a significant neuropathogen, retrospectively detecting the virus in approximately 27% (6/22) of cattle with non-suppurative encephalitis of unknown etiology [3]. This finding was pivotal, as it established a novel neurotropic pathotype for BoAstV, distinct from the classical enteric strains. The Swiss research identified two distinct neurotropic strains: BoAstV-CH13 and BoAstV-CH15, the latter of which was found in a cow initially suspected of having bovine spongiform encephalopathy (BSE) [3]. This discovery has profound implications for the differential diagnosis of neurological diseases in cattle, particularly in BSE surveillance programs, where astrovirus-induced encephalitis could be a confounding factor.

In Asia, BoAstV has been extensively documented in China, Japan, and South Korea, where it is frequently associated with neonatal calf diarrhea. The genetic diversity of BoAstV in Asia is high, with multiple genotypes co-circulating within and between herds. In the Americas, beyond the aforementioned study in Colombia, BoAstV has been reported in the United States, Canada, and Brazil. The North American studies have been instrumental in characterizing the neurotropic strains, with the first description of BoAstV NeuroS1 from a calf with encephalitis in the USA [3]. The detection of BoAstV in Central Colombia [2] is particularly noteworthy as it fills a significant gap in the epidemiological map of South America, a region with a massive cattle population. The Colombian study used a convenient non-probabilistic sampling method, which may introduce selection bias, but the findings provide a crucial baseline for future, more systematic surveillance efforts in the region [2].

Neurotropic Astroviruses: A New Epidemiological Paradigm

The identification of BoAstV as a causative agent of non-suppurative encephalitis in cattle represents a major paradigm shift in our understanding of astrovirus pathogenesis and epidemiology. Historically, astroviruses were considered primarily enteric pathogens. The discovery of neurotropic strains, phylogenetically distinct from classical enteric isolates, has opened a new chapter in veterinary neurovirology. The Swiss study by Seuberlich et al. (2016) demonstrated that BoAstV-CH13 and BoAstV-CH15 were responsible for a substantial proportion of previously undiagnosed encephalitis cases in Swiss cattle [3]. The clinical presentation of these cases can be variable, ranging from subtle behavioral changes to severe neurological deficits, including ataxia, hyper-reactivity, and recumbency, often mimicking BSE [3]. The full genome phylogenetic analysis placed these neurotropic bovine astroviruses in the same clade as other neurotropic astroviruses, including the HMO clade of human astroviruses associated with encephalitis in immunocompromised patients, and an ovine astrovirus (OvAstV) [3]. This phylogenetic clustering suggests a common ancestral origin or a conserved mechanism of neuroinvasion among these viruses.

The epidemiology of neurotropic BoAstV is poorly understood. It is unclear whether these strains originate from enteric infections that subsequently invade the central nervous system (CNS) via the bloodstream or peripheral nerves, or if they represent a distinct, neurotropic pathotype that primarily replicates in neural tissue. The detection of BoAstV-CH13 and BoAstV-CH15 in the medulla oblongata, cerebellum, and cerebral cortex of affected animals confirms their ability to establish a robust infection within the CNS [3]. The fact that these viruses were detected in a retrospective study of archived brain tissue suggests that neurotropic BoAstV infections may be an underdiagnosed cause of neurological disease in cattle globally. The potential for cross-species transmission, as suggested by the close phylogenetic relationship between BoAstV-CH15 and OvAstV [3], raises concerns about the role of livestock in the ecology of neurotropic astroviruses and the potential for zoonotic spillover, although no such event has been documented to date. The World Organisation for Animal Health (WOAH) and the World Health Organization (WHO) recognize the importance of monitoring emerging neurotropic viruses in livestock, as they can have significant implications for animal health, food safety, and public health.

Co-infection Dynamics and the Role of Metagenomics

A defining epidemiological feature of BoAstV is its frequent involvement in polymicrobial infections. The virus is rarely detected as a sole pathogen, particularly in cases of diarrhea. Co-infections with other enteric viruses (e.g., bovine rotavirus, bovine coronavirus, bovine norovirus, bovine kobuvirus), bacteria (e.g., E. coli, Salmonella spp.), and protozoa (e.g., Cryptosporidium parvum) are the rule rather than the exception [1, 2]. This complex co-infection landscape makes it exceedingly difficult to attribute clinical disease to BoAstV alone. The Colombian metagenomic study vividly illustrated this point, showing that BoAstV was often present in fecal samples alongside high abundances of Enterovirus E and Bovine Kobuvirus [2]. This suggests that BoAstV may act as an opportunistic pathogen, exacerbating disease caused by other agents, or that its replication is enhanced by the inflammatory environment created by a primary infection.

The application of viral metagenomics has been transformative for BoAstV epidemiology. Unlike targeted PCR assays, which can only detect known viruses, metagenomic sequencing provides an unbiased view of the entire viral community in a sample. This approach has been instrumental in discovering novel BoAstV genotypes, such as the neurotropic strains, and in revealing the true diversity of astroviruses in cattle. The study by Medina et al. (2023) in Colombia is a prime example of how metagenomics can be deployed for surveillance in resource-limited settings, using portable sequencing platforms like Oxford Nanopore Technologies [2]. However, the sensitivity of metagenomics can be influenced by sequencing depth and the choice of reference genome, as demonstrated by Brito et al. (2026) in their work on bovine respiratory viruses [7]. Their study showed that for viruses like Bovine Nidovirus and Bovine Coronavirus, a sequencing depth of at least 10 million reads was required for reliable detection in samples with high Ct values (low viral loads) [7]. This methodological consideration is critical for interpreting metagenomic data on BoAstV, as low-level shedding in healthy carriers may be missed if sequencing depth is insufficient. The development of targeted next-generation sequencing (tNGS) panels, which use primers to enrich for specific pathogen genomes, offers a promising middle ground, providing the high sensitivity of PCR with the broad detection capability of NGS [4]. Such approaches could be highly valuable for routine surveillance of BoAstV and other bovine pathogens in diagnostic laboratories.

Risk Factors and Transmission Dynamics

The transmission of BoAstV is primarily via the fecal-oral route, with contaminated feed, water, and fomites serving as major vehicles. The virus is shed in high concentrations in the feces of infected animals, both clinically ill and asymptomatic. The stability of astroviruses in the environment is a key factor in their persistence on farms. As non-enveloped viruses, BoAstV is resistant to many common disinfectants and can survive for extended periods in manure, slurry, and contaminated bedding. This environmental persistence facilitates rapid spread within a herd, particularly among young calves housed in group pens. Age is a significant risk factor, with the highest prevalence of infection and disease typically observed in neonatal and pre-weaned calves, likely due to their immature immune systems. Maternal antibodies acquired through colostrum may provide some protection, but the duration and efficacy of this passive immunity against diverse BoAstV genotypes are unknown.

Management practices play a crucial role in the epidemiology of BoAstV. High stocking density, poor hygiene, inadequate ventilation, and mixing of animals from different sources are all associated with increased transmission. The movement of cattle, particularly the introduction of new animals into a herd, is a major risk factor for the introduction of novel BoAstV strains. This is analogous to the risk factors identified for other bovine pathogens, such as Brucella abortus, where the purchase of animals from other farms was a significant risk factor for seropositivity in organized dairy herds in India [8]. Similarly, for BoAstV, biosecurity measures such as quarantine of new arrivals, all-in-all-out management of calf housing, and rigorous cleaning and disinfection protocols are essential for controlling spread. The role of other domestic and wild animals in the epidemiology of BoAstV is an area of active investigation. The close phylogenetic relationship between bovine and ovine astroviruses [3] raises the possibility of interspecies transmission, and cattle could potentially acquire infections from sheep or goats sharing the same pasture. The potential for cross-species transmission, as highlighted by Zhu et al. (2022) [1], warrants further investigation, particularly in mixed-species farming systems, and is a concern for public health authorities such as the CDC and FAO, given the potential for viral adaptation to new hosts.

Clinical Manifestations and Co-Infection Dynamics in Bovine Astrovirus

Bovine astrovirus (BoAstV) presents a uniquely challenging paradigm in veterinary virology, characterized by a perplexing dichotomy between its widespread detection in both healthy and clinically diseased cattle and its elusive definitive pathogenic role. As comprehensively outlined by Zhu et al. [1], BoAstV exhibits a remarkably broad tissue tropism, capable of infecting the intestinal tract, nervous system, and respiratory tract. This polysystemic potential, however, is accompanied by a persistent epidemiological ambiguity: the virus is frequently isolated from asymptomatic, apparently healthy animals with equal or greater prevalence than from clinically affected cohorts. This foundational paradox necessitates a deep and critical examination of the specific clinical scenarios where BoAstV is implicated, coupled with an exhaustive analysis of its near-ubiquitous co-infection dynamics, which likely mask or modulate its true pathogenic contribution. Understanding these manifestations and interactions is not merely an academic exercise; it is essential for informing diagnostic algorithms, refining causal inference in disease outbreaks, and developing rational control strategies for what may be a significant, yet underappreciated, component of the bovine disease complex.

The Clinical Spectrum: From Subclinical Carriage to Severe Neurological Disease

The clinical manifestations associated with BoAstV infection span a striking spectrum, from the most common state of subclinical enteric shedding to severe, life-threatening encephalitis. The most frequently reported presentation is its association with neonatal calf diarrhea (NCD). Since its initial discovery in diarrheic calf feces in the United Kingdom in 1978 [1], BoAstV has been consistently identified in enteric samples from calves with gastroenteritis. However, the strength of this association is profoundly weakened by the virus's equally high prevalence in healthy, non-diarrheic controls across numerous studies [1]. This observation has led to the prevailing, albeit cautious, hypothesis that BoAstV, particularly the classic enteric genotypes, is frequently an apathogenic or mildly opportunistic commensal of the gut, requiring specific predisposing factors, such as host immune immaturity, nutritional stress, or, most critically, concurrent infections, to precipitate overt clinical disease. The clinical signs attributable to BoAstV in enteric cases, when they do occur, are typically non-specific and indistinguishable from other viral enteritides, including watery to bloody diarrhea, anorexia, dehydration, and lethargy. The severity is highly variable and rarely documented as singularly attributable to BoAstV due to the complexity of the co-infection landscape.

In stark contrast to the ambiguity of the enteric form, a far more definitive and alarming clinical manifestation has emerged: BoAstV as a causative agent of non-suppurative encephalitis in cattle. This neurotropic phenotype represents a paradigm shift in our understanding of astrovirus pathogenesis. Pioneering work by Seuberlich et al. [3] has been instrumental in establishing this link, identifying two distinct, phylogenetically novel BoAstV strains, BoAstV-CH13 and the subsequently identified BoAstV-CH15, in the central nervous system (CNS) of cattle with severe, idiopathic encephalitis. The clinical presentation in these cases is profound and often dramatic, mimicking notifiable diseases such as bovine spongiform encephalopathy (BSE). The index case for BoAstV-CH15 was a 4-year-old Braunvieh cow reported as a BSE suspect, exhibiting a spectrum of signs typical of neurological dysfunction, including changes in behavior and temperament, hyper-reactivity, and incoordination [3]. Histopathological examination of these cases consistently reveals a severe, non-suppurative meningo-encephalomyelitis, a hallmark of viral infection, characterized by perivascular cuffing, gliosis, and neuronal necrosis [3]. The identification of BoAstV-CH13 in approximately one-quarter of a retrospective cohort of etiologically unresolved encephalitis cases, and the subsequent discovery of BoAstV-CH15 in additional cases from the same set, underscores the significance of this pathogen in the bovine neurological disease complex [3]. Critically, the clinical signs of neurotropic BoAstV are not pathognomonic, meaning a definitive diagnosis cannot be made on clinical grounds alone and requires advanced molecular diagnostics, such as next-generation sequencing (NGS) targeted at brain tissue, to differentiate it from other viral encephalitides like rabies, BVDV, or BoHV-5. The high mortality associated with these neurological cases positions neurotropic BoAstV as a serious, emerging pathogen of considerable veterinary and economic concern, potentially having a significant impact on both animal welfare and production.

The Primacy of Co-Infection: A Sea of Polymicrobial Background

The most critical factor complicating the assessment of BoAstV's clinical role is its almost invariant presence within a complex polymicrobial environment. As stated by Zhu et al. [1], BoAstV is "mostly associated with co-infection with other viruses," a finding that fundamentally shapes our understanding of its pathogenesis. This reality is not an occasional occurrence but appears to be the rule, particularly in enteric disease, where it is a member of a vast and unstable viral ecosystem.

Viral metagenomic studies have been instrumental in revealing the sheer scale of this co-infection. A comprehensive survey of fecal samples from cattle in Colombia by Medina et al. [2] demonstrated that BoAstV was a core component of the bovine enteric virome, co-circulating most prominently with Enterovirus E (EVE) and Bovine Kobuvirus (BKV). The study reported detection frequencies of 59% for EVE, 52% for BKV, and 19% for BoAstV [2], indicating that co-infection with at least one of these other enteric pathogens is statistically highly probable. This polymicrobial context makes it exceptionally difficult to attribute clinical signs like diarrhea to any single agent, as the combined effect of multiple viruses may be synergistic, additive, or even competitive. The detection of BoAstV in a diarrheic sample might be incidental, representing a "passenger" virus, or it could be a critical "driver" of pathology that only becomes apparent when the host is already compromised by another pathogen. This interaction is not merely a diagnostic nuisance; it may be central to the expression of disease. For instance, the initial damage caused by EVE or BKV might disrupt the intestinal epithelial barrier, facilitating BoAstV invasion or enhancing its replication, tipping the balance from subclinical shedding to clinical enteritis.

The implications of co-infection extend far beyond the gastrointestinal tract. In the more severe neurological form, while monoinfection is strongly implied by the presence of BoAstV alone in brain tissue lesions [3], the initial entry and dissemination of the virus may be primed by a systemic co-infection. A respiratory viral infection, such as with Bovine Coronavirus (BCoV) or Bovine Viral Diarrhea Virus (BVDV-1) as detected by Brito et al. [7], could compromise the host's immune defenses, allowing a neurotropic BoAstV strain to breach the blood-brain barrier. The complex interplay of these pathogens on the host's immune system, particularly the interferon response, could dictate the outcome of BoAstV infection. The detection of BoAstV in both the respiratory tract and nervous system [1] suggests a potential route of neuroinvasion following primary respiratory infection, a pathway that is likely enhanced by the inflammation and immune dysregulation caused by co-infecting respiratory viruses. This hierarchical model of pathogenesis, where a primary pathogen creates the niche for a secondary one, is a critical area for future research and highlights the inadequacy of studying BoAstV as a solitary entity.

Diagnostic and Pathogenic Consequences of the Co-Infection Dynamics

The entangled nature of BoAstV infection has profound consequences for both diagnosis and our mechanistic understanding of its pathology. From a diagnostic perspective, the high prevalence of BoAstV in healthy animals means that a simple positive PCR result from a fecal swab or respiratory sample has very poor positive predictive value for clinical disease. This forces a reliance on quantitative RT-PCR, though its utility is debated, or more sophisticated methods like metatranscriptomic sequencing, as advocated by Brito et al. [7] and Liu et al. [5], which can simultaneously and untargetedly profile the entire RNA virome. As demonstrated in proficiency tests for porcine astrovirus [5], the ability of metagenomics to detect and quantify multiple viral species in a single run offers the only plausible pathway to unraveling the complex interactions between BoAstV and its co-infecting partners. Such an approach could enable the development of "pathogenicity scores" or "risk algorithms" that weigh a specific combination and abundance of co-infecting agents to predict the likelihood of disease.

Pathogenically, the co-infection dynamic suggests that BoAstV, particularly its enteric forms, may function primarily as an immunomodulator or a potentiator of disease caused by other agents. The lack of a stable, passageable cell culture system [1] has severely hampered in vitro studies of these interactions. However, it is plausible that BoAstV could downregulate innate antiviral responses, such as the type I interferon pathway, thereby facilitating the replication of co-infecting viruses like BCoV or Bovine Rotavirus. This would be analogous to the role of the human astrovirus, which is increasingly recognized for its ability to modulate the host immune response and cause disease primarily in the context of immunodeficiency. The presence of a robustly replicating BoAstV in a healthy animal suggests a highly tuned host-pathogen equilibrium. When this equilibrium is disturbed, for instance, by the stress of weaning or the introduction of a highly pathogenic co-virus, the balance can tip, leading to clinical disease. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have highlighted the economic burden of livestock diseases, particularly those with complex etiologies like neonatal diarrhea and bovine respiratory disease (BRD). The realization that BoAstV is a common component of these polymicrobial syndromes, potentially acting as a predisposing factor, has strategic implications for disease control, moving the focus from single-pathogen vaccines to broader management strategies that enhance overall host resilience and limit the circulation of the entire viral consortium.

Diagnostic Approaches and Detection Methods for Bovine Astrovirus

The detection of bovine astrovirus (BoAstV) presents a unique set of challenges and opportunities that distinguish it from many other viral pathogens of cattle. Unlike agents such as bovine viral diarrhea virus (BVDV) or bovine herpesvirus-1, for which standardized, commercially available diagnostic platforms are widely deployed, BoAstV diagnostics remain largely confined to research and reference laboratories. This reality stems from the virus’s complex biology, its frequent occurrence as a co-pathogen, and the absence of robust cell culture systems for routine isolation [1]. Consequently, the diagnostic landscape for BoAstV is dominated by nucleic acid-based detection methods, increasingly supplemented by high-throughput sequencing technologies, while serological approaches remain underdeveloped. The World Organisation for Animal Health (WOAH) has not yet established standardized diagnostic protocols for BoAstV, underscoring the need for rigorous validation of the methods described herein.

Molecular Detection: The Cornerstone of BoAstV Diagnosis

Conventional and Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)

The primary diagnostic modality for BoAstV is the detection of viral RNA via reverse transcription polymerase chain reaction (RT-PCR). Given that BoAstV is a single-stranded positive-sense RNA virus with a genome organization comprising three open reading frames (ORF1a, ORF1b, and ORF2), most molecular assays target highly conserved regions within the RNA-dependent RNA polymerase (RdRp) gene in ORF1b or the capsid protein gene in ORF2 [1, 3]. The design of these primers is critical, as the genetic diversity among BoAstV strains, particularly between enteric and neurotropic genotypes, can lead to false-negative results if assays are too narrowly targeted. For instance, the discovery of BoAstV-CH15, a second encephalitis-associated astrovirus in cattle with less than 65% genetic similarity to known isolates, was achieved not through a specific diagnostic test but through unbiased next-generation sequencing, highlighting the limitations of targeted RT-PCR for detecting novel or divergent strains [3].

Quantitative RT-PCR (RT-qPCR) assays, particularly those employing SYBR Green I or TaqMan chemistries, offer significant advantages in sensitivity and quantification over conventional end-point PCR. Drawing from methodologies validated for other bovine RNA viruses, such as bovine ephemeral fever virus (BEFV), where SYBR Green I-based RT-qPCR demonstrated analytical sensitivity approximately 100 times higher than conventional RT-PCR, similar performance characteristics can be expected for BoAstV [16]. The precision of such assays, as measured by intra-assay and inter-assay coefficients of variation, is typically excellent, often falling below 2% [16]. For BoAstV, RT-qPCR enables not only detection but also viral load quantification, which is essential for understanding pathogenesis, particularly in distinguishing active infection from incidental viral shedding. The selection of appropriate reference genes for normalization, such as peptidylprolyl isomerase A (PPIA) used in BEFV studies, is a critical but often overlooked aspect of RT-qPCR assay development for BoAstV [16].

Multiplex and Pan-Astrovirus Assays

Given the high prevalence of co-infections in bovine enteric and respiratory disease, multiplex molecular panels that simultaneously detect BoAstV alongside other pathogens are of considerable diagnostic utility. Viral metagenomic studies have consistently demonstrated that BoAstV frequently co-occurs with enterovirus E (EVE), bovine kobuvirus (BKV), and other enteric agents [2]. A targeted next-generation sequencing (NGS) approach, employing 198 primers designed to amplify genomic regions of 43 common bovine pathogens, including viruses, bacteria, fungi, and parasites, has been successfully validated for clinical samples [4]. This method demonstrated the ability to detect organisms from samples with quantitative PCR (qPCR) threshold cycle (Ct) values in the 30s, successfully identifying multiple pathogens in single clinical specimens, including some missed by routine diagnostic techniques [4]. Such comprehensive approaches are particularly valuable for BoAstV, where its pathogenic role is often obscured by concurrent infections.

Metagenomic and Next-Generation Sequencing: Unbiased Pathogen Discovery

Shotgun Metagenomic Sequencing (mNGS)

The most transformative advancement in BoAstV diagnostics has been the application of shotgun metagenomic sequencing (mNGS). This culture-independent, untargeted approach has been instrumental not only in detecting BoAstV but in discovering novel genotypes and understanding its tissue tropism. The identification of BoAstV-CH13 and BoAstV-CH15 in cases of bovine non-suppurative encephalitis was accomplished exclusively through unbiased RNA sequencing of brain tissue, followed by in silico subtraction of host sequences and de novo assembly of viral contigs [3]. This pipeline, which generated over 21 million read pairs from a single brain sample, identified contiguous sequences matching astrovirus proteins with 64–83% amino acid similarity to ovine astrovirus, ultimately revealing a novel neuroinvasive astrovirus [3].

The diagnostic performance of metatranscriptomic sequencing is heavily influenced by sequencing depth and reference genome selection. Systematic evaluation of these parameters for bovine respiratory RNA viruses, including bovine coronavirus, bovine nidovirus, influenza D virus, and BVDV-1, has provided critical insights applicable to BoAstV detection. Sequencing depths of 10 million reads or more were sufficient for detection of samples that were qRT-PCR positive at high Ct values (up to 40), but recovering high genome completeness required samples with Ct values below 30 [7]. Importantly, the choice of reference genome dramatically affects detection sensitivity; mapping to study-assembled genomes markedly increased read counts and coverage compared to NCBI RefSeq sequences, reflecting divergence between field strains and standard references [7]. This finding is particularly relevant for BoAstV, given its substantial genetic heterogeneity.

Bioinformatic Considerations and Standardization

The bioinformatic analysis of mNGS data for BoAstV detection presents unique challenges. Inter-laboratory proficiency testing using porcine astrovirus as a model RNA virus in fecal material revealed that while all participants successfully identified and classified viral reads to the dominant species, normalized read counts differed substantially between laboratories due to variations in laboratory methods for data generation [5]. The selection of appropriate reference databases for read classification is crucial; virus- or sample-specific biases may apply, and caution is needed when extrapolating performance characteristics across different sample types or viral families [5]. For BoAstV, the use of Kraken read classifiers combined with Bowtie2 alignment to astrovirus reference genomes has shown good concordance, but the importance of using comprehensive, phylogenetically diverse reference sequences cannot be overstated [5].

Diagnostic Challenges Specific to BoAstV

The Problem of Subclinical Shedding and Co-Infection

A fundamental diagnostic challenge for BoAstV is its high prevalence in both healthy and clinically affected animals. Viral metagenomic surveys have detected BoAstV in 19% of fecal samples from cattle in Colombia, with notable frequencies alongside other potentially pathogenic viruses [2]. This widespread occurrence in clinically normal animals complicates the interpretation of a positive diagnostic result. Unlike BVDV, where detection of persistently infected (PI) animals through ear-notch tissue testing and RT-PCR has been central to successful eradication programs [13], no equivalent pathognomonic diagnostic strategy exists for BoAstV. The virus’s association with co-infections, often involving enterovirus E, bovine kobuvirus, or other agents, means that attributing clinical disease solely to BoAstV requires quantitative viral load data, histopathological correlation, or exclusion of other pathogens [2, 4].

Tissue Tropism and Sample Selection

BoAstV exhibits wide tissue tropism, infecting the intestine, nervous tissue, and respiratory tract [1]. This diversity necessitates careful sample selection based on clinical presentation. For enteric disease, fecal samples or intestinal contents are appropriate, while for neurological cases, brain tissue, particularly the medulla oblongata, cerebellar cortex, midbrain, and cerebral cortex, is required [3]. The detection of BoAstV in milk, analogous to findings for bovine herpesvirus-5 [18], has not been systematically investigated but represents a potential avenue for non-invasive sampling. The stability of BoAstV RNA in different sample matrices and under various storage conditions remains poorly characterized, though the virus’s non-enveloped nature suggests relative environmental stability.

Absence of Cell Culture and Serological Tools

The lack of stable passage cell lines for BoAstV isolation remains a critical gap [1]. Virus isolation, the traditional gold standard for many viral pathogens, is not routinely available, forcing reliance on molecular detection alone. Furthermore, serological assays, such as enzyme-linked immunosorbent assays (ELISA) or virus neutralization tests, are not commercially available for BoAstV. This absence precludes the use of serosurveillance strategies that have been so effective for other bovine viruses, such as the agar gel immunodiffusion (AGID) test for enzootic bovine leukosis [12] or the Rose Bengal plate test and complement fixation test for brucellosis [8, 10]. The development of recombinant capsid protein-based ELISA systems, similar to those used for BVDV antibody detection [14], would represent a major advance, enabling population-level seroprevalence studies and investigation of immune responses following natural infection.

Emerging and Alternative Diagnostic Approaches

Phage-Based and Novel Detection Platforms

While not yet applied to BoAstV, innovative detection platforms developed for other bovine pathogens offer potential future applications. The phagomagnetic separation (PhMS)-qPCR assay, developed for rapid detection of viable Mycobacterium avium subsp. paratuberculosis in milk and feces, demonstrates the feasibility of combining phage-based capture with molecular detection [11]. Similar approaches could theoretically be adapted for BoAstV if specific ligands or antibodies become available. Lateral flow assays (LFAs), which have shown high sensitivity (∼87%) and specificity (∼97%) for bovine brucellosis antibody detection in field settings [19], could be developed for BoAstV antigen detection once suitable monoclonal antibodies are generated.

Lipidomics and Metabolomics

The application of lipidomics to detect bacterial infections, as demonstrated for bovine paratuberculosis where unique bacterial lipids such as phthiodiolone dimycocerosates and trehalose monomycolates were monitored in serum [15], represents a novel diagnostic frontier. While viruses do not possess lipid biosynthetic machinery, virus-induced alterations in host lipid metabolism could theoretically serve as indirect biomarkers of BoAstV infection. This approach remains speculative but warrants investigation given the limitations of current diagnostic tools.

Quality Assurance and Inter-Laboratory Standardization

The reliability of BoAstV diagnostics depends critically on quality assurance measures. Inter-laboratory comparisons, such as those conducted for BVDV diagnosis using standardized control sera panels [14], are essential for ensuring reproducibility across laboratories. The development of reference materials, analogous to the BOTS-1 certified reference material for veterinary drug residues, which underwent rigorous characterization including assessment of homogeneity, stability, and uncertainty [9], would greatly enhance the reliability of BoAstV molecular diagnostics. Proficiency testing programs, similar to those established for metagenomic detection of RNA viruses in swine feces [5], should be extended to include BoAstV. The evaluation of laboratory diagnostic surveillance systems, as performed for five cattle diseases in France using the OASIS method, highlights the importance of formalized reporting guidelines, feedback mechanisms, and case definitions [17]. These principles are directly applicable to BoAstV, where the absence of standardized case definitions for laboratory diagnostic surveillance remains a significant weakness.

Evolutionary Analysis and Genetic Diversity of Bovine Astrovirus

The evolutionary trajectory and genetic heterogeneity of bovine astrovirus (BoAstV) represent a critical frontier in understanding its ecology, pathobiology, and potential for cross-species transmission. Since its initial identification in 1978 from diarrheic calf feces in the United Kingdom, BoAstV has emerged as a taxonomically and genetically complex viral entity, defying simplistic classification and challenging conventional assumptions regarding host restriction and tissue tropism [1]. The advent of unbiased high-throughput sequencing technologies has fundamentally reshaped our comprehension of astrovirus diversity, revealing a spectrum of genetically distinct lineages that circulate within bovine populations and, critically, uncovering neurotropic variants that possess the capacity to invade the central nervous system (CNS) and cause severe encephalitis. This section synthesizes the current state of knowledge regarding the phylogenetic architecture, evolutionary dynamics, and genetic variability of BoAstV, drawing upon metagenomic surveillance data, comparative genomic analyses, and targeted molecular epidemiological studies.

Phylogenetic Architecture and Genogroup Classification

The genetic landscape of BoAstV is characterized by remarkable diversity, a feature that is increasingly recognized as a hallmark of the Astroviridae family as a whole. Comprehensive phylogenetic analyses based on complete genome sequences and, more commonly, on partial sequences of the RNA-dependent RNA polymerase (RdRp) gene within open reading frame 1b (ORF1b) and the capsid protein gene within ORF2, have consistently resolved BoAstV isolates into multiple distinct genogroups [1]. These genogroups, often designated as BoAstV-A, BoAstV-B, and BoAstV-C, exhibit inter-group nucleotide sequence identities that can fall below 60–70% for the capsid gene, a level of divergence that approaches the criteria used to define novel astrovirus species within the Mamastrovirus genus. The degree of genetic heterogeneity observed among bovine astroviruses is not merely an academic curiosity; it has profound implications for diagnostic detectability, as PCR assays designed to target conserved regions of one genogroup may fail to amplify viruses belonging to another, leading to substantial underestimation of true prevalence.

The ORF2 gene, which encodes the structural capsid protein responsible for host cell receptor binding and immune recognition, is the primary driver of this antigenic and genetic diversity. Within a single genogroup, the capsid protein can exhibit hypervariable regions that are subject to intense positive selection pressure, likely driven by host immune responses. This phenomenon is not unique to BoAstV but is observed across the Astroviridae; however, the degree of intra-host and intra-herd capsid diversity documented in bovine populations suggests a particularly dynamic evolutionary process. The presence of multiple, co-circulating genogroups within the same geographic region and even within the same individual animal raises critical questions regarding the mechanisms of viral persistence, the potential for genetic recombination, and the nature of protective immunity. Recombination events, particularly between the RdRp and capsid genes from different genogroups, have been documented in other astroviruses and are suspected to occur in BoAstV, potentially generating novel chimeric viruses with altered tropism or pathogenicity.

Discovery and Phylogenetic Position of Neurotropic Bovine Astroviruses

Perhaps the most paradigm-shifting advance in BoAstV research has been the discovery of genetically distinct, neuroinvasive strains capable of causing non-suppurative encephalitis in cattle. This finding has fundamentally expanded our conceptualization of astrovirus pathogenesis, moving beyond the classic enteric disease model to include severe neurological disease. The sentinel work by Seuberlich and colleagues in Switzerland, and parallel investigations in the United States, identified two phylogenetically distinct neurotropic bovine astroviruses, designated BoAstV-CH13 and BoAstV-CH15, that were retrospectively detected in brain tissue from cattle with etiologically unresolved CNS inflammation [3]. The identification of BoAstV-CH15 is particularly instructive from an evolutionary perspective.

BoAstV-CH15 was discovered through unbiased next-generation sequencing (NGS) of RNA extracts from the medulla oblongata of a four-year-old Braunvieh cow that had presented as a clinical suspect for bovine spongiform encephalopathy (BSE) but tested negative for prion disease [3]. Histopathological examination revealed severe, non-suppurative meningo-encephalomyelitis, a pattern strongly suggestive of viral etiology. The de novo assembly of NGS reads yielded contigs that shared only 64–83% amino acid sequence similarity with the closest known astrovirus, an ovine astrovirus isolate (OvAstV) [3]. This low level of identity immediately positioned BoAstV-CH15 as a highly divergent lineage. Full-genome phylogenetic analysis placed BoAstV-CH15 firmly within the HMO clade (human, mink, ovine) of the Mamastrovirus genus, a cluster that includes other neurotropic astroviruses from humans (e.g., HAstV-VA1/HMO-C) and minks [3]. Crucially, BoAstV-CH15 rooted from the same branch as the ovine astrovirus and was phylogenetically distant from both classical human enteric astroviruses and the previously described bovine enteric isolates.

This phylogenetic placement carries several profound implications. First, it suggests a common ancestry for neurotropic astroviruses infecting disparate mammalian hosts, raising the possibility of a shared genetic determinant of neuroinvasiveness. Second, the close relationship between BoAstV-CH15 and an ovine astrovirus isolated from fecal samples of a sheep with diarrhea highlights the potential for cross-species transmission events in the evolutionary history of these viruses. The capsid protein of BoAstV-CH15, which governs receptor binding and cell entry, may possess structural features that facilitate entry into neuronal cells, a property that is not readily predicted from sequence alone. Importantly, the detection of BoAstV-CH15 in two out of 22 cases of previously unexplained non-suppurative encephalitis in the Swiss cohort, including one animal that was also positive for BoAstV-CH13, indicates that co-infection with multiple neurotropic astrovirus strains can occur and that these viruses likely account for a significant proportion (approximately one-quarter) of previously idiopathic bovine encephalitis cases [3].

Genetic Diversity Revealed by Metagenomic Surveillance

The application of viral metagenomics to bovine fecal samples has dramatically expanded our appreciation of BoAstV genetic diversity on a global scale. Studies employing both short-read (Illumina) and long-read (Oxford Nanopore) sequencing technologies have consistently identified BoAstV as a core component of the bovine enteric virome, often co-occurring with other RNA viruses such as Enterovirus E (EVE) and Bovine Kobuvirus (BKV) [2]. In a seminal metagenomic survey conducted in the Ubaté Province of Colombia, the country’s dairy capital, BoAstV was detected in 19% of fecal samples using Oxford Nanopore sequencing, marking the first formal description of this virus in Colombian cattle [2]. The phylogenetic analysis of the partial viral sequences obtained in this study revealed that the Colombian BoAstV strains grouped with sequences previously reported from Asia and Latin America, underscoring the importance of geographic representation in understanding global phylogeography [2]. The sequence diversity observed within this relatively small geographic area was notable, suggesting that multiple genogroups or variants are co-circulating within the region.

The detection of BoAstV at such notable frequencies (19% in Colombia, and often higher in other international studies) in both healthy and clinically affected animals complicates the interpretation of its pathogenic role. From an evolutionary standpoint, the ability of a virus to persist at high prevalence within a host population without causing overt disease in a majority of infected animals represents a successful evolutionary strategy. However, the same genetic plasticity that allows for asymptomatic enteric replication may also enable the occasional emergence of neurotropic variants. The selective pressures that drive a virus from the enteric tract to the CNS remain completely unknown but are likely to involve a combination of viral genetic determinants (e.g., specific mutations in the capsid spike domain), host immune status (e.g., immunosuppression due to co-infection with BVDV or stress), and stochastic events.

Methodological Considerations and the Impact of Reference Genome Choice on Evolutionary Inference

The accurate characterization of BoAstV genetic diversity is critically dependent on the methodological frameworks employed for detection and analysis. The lessons learned from other bovine RNA viruses, such as Bovine Viral Diarrhea Virus (BVDV-1) and Bovine Nidovirus (BNV), are directly applicable to BoAstV. Studies have quantitatively demonstrated that read recovery and genome completeness in metatranscriptomic sequencing are strongly influenced by both sequencing depth and, most importantly, the choice of reference genome for read mapping [7]. For BVDV-1, mapping to study-assembled genomes (i.e., genomes assembled de novo from the same sequencing run) markedly increased the number of mapped reads and the breadth of genome coverage compared to mapping to the standard NCBI RefSeq genome, reflecting the substantial sequence divergence between field strains and the laboratory-adapted reference [7].

This phenomenon is acutely relevant to BoAstV. Given the high genetic diversity described above and the existence of multiple distinct genogroups, a sequencing effort that relies solely on mapping reads to a single reference genome (e.g., the original enteric BoAstV isolate) will systematically underestimate the prevalence and diversity of highly divergent strains, such as BoAstV-CH15. The use of de novo assembly approaches, followed by taxonomic binning of assembled contigs against a comprehensive database of all known astrovirus sequences (including those from humans, sheep, mink, and other species), is essential to capture the full extent of genetic variation. This is particularly critical for surveillance programs aimed at detecting the emergence of novel neurotropic strains. Furthermore, the findings from inter-laboratory proficiency tests using metagenomic sequencing for porcine astroviruses have highlighted that both laboratory processing methods and the selection of reference data for read classification introduce substantial variability in normalized read counts [5]. Extrapolating these findings to bovine astrovirus, it is clear that standardized bioinformatic pipelines and curated, regularly updated reference databases are prerequisites for robust evolutionary analysis and for the reliable detection of emerging variants.

In conclusion, the evolutionary analysis of bovine astrovirus reveals a pathogen in a state of active genetic flux, characterized by multiple co-circulating genogroups, the presence of highly divergent neurotropic lineages within the HMO clade, and a global phylogeography that is only beginning to be mapped. The capacity of this virus to cause severe neurological disease, as demonstrated by BoAstV-CH13 and BoAstV-CH15, represents a major shift in our understanding of astrovirus pathogenesis and underscores the necessity for enhanced surveillance that integrates unbiased metagenomic approaches. The genetic determinants governing host range, tissue tropism, and the transition from enteric to neuroinvasive infection remain enigmatic but represent a high-priority area for future research. Given the potential for cross-species transmission and the economic importance of both enteric and neurological disease in cattle, continued evolutionary surveillance of BoAstV is not merely an academic exercise but a critical component of veterinary biosecurity and One Health preparedness.

Cross-Species Transmission Potential and Zoonotic Implications of Bovine Astrovirus

Phylogenetic Relationships and Neurotropic Astroviruses

Bovine astrovirus (BoAstV) occupies a distinct but evolutionarily fluid position within the Astroviridae family, a lineage of small, non-enveloped, positive-sense single-stranded RNA viruses that have traditionally been associated with gastroenteritis in young mammals and birds. However, the discovery of neurotropic astrovirus strains in both humans and livestock has fundamentally reshaped our understanding of the zoonotic and cross-species transmission potential of these agents. The comprehensive review by Zhu et al. [1] explicitly raises the possibility of cross-species transmission for BoAstV, noting that the virus has been detected in bovines across multiple continents, including the United Kingdom, the United States, Switzerland, Colombia, and China, and exhibits a wide tissue tropism encompassing the intestine, nervous system, and respiratory tract. This broad tissue distribution is a hallmark of viruses with the capacity to adapt to new hosts, as neural invasion often requires specific receptor interactions that may be conserved across mammalian species.

The most compelling evidence for cross-species transmission potential comes from genomic analyses of neuroinvasive astroviruses. Seuberlich et al. [3] identified a second encephalitis-associated bovine astrovirus, designated BoAstV-CH15, from a cow presenting with non-suppurative meningo-encephalomyelitis in Switzerland. Full-genome phylogenetic analysis placed BoAstV-CH15 within the same cluster as previously described neurotropic astroviruses (the HMO clade), which includes human encephalitis-associated astroviruses such as HuAstV-PS, as well as ovine astrovirus (OvAstV) isolated from sheep feces. Importantly, BoAstV-CH15 rooted from the same branch as OvAstV, sharing up to 83% amino acid identity in ORF1b and ORF2 regions, and exhibited less than 65% genetic similarity to classical bovine and human fecal astrovirus isolates [3]. This genetic proximity to ovine astrovirus, which itself was recovered from a diarrheic lamb, strongly suggests that astroviruses have crossed the species barrier between sheep and cattle, and that the HMO clade may represent a cross-species transmissible lineage with the capacity to infect multiple ungulate hosts and, critically, humans.

Evidence for Cross-Species Transmission

The biological mechanisms underpinning this cross-species potential are multifaceted. Astroviruses, like other RNA viruses, possess high mutation rates and frequent recombination events, allowing them to rapidly adapt to new host environments. The HMO clade astroviruses, including BoAstV-CH15 and BoAstV-CH13 (a previously identified neurotropic strain), share conserved capsid and non-structural protein domains that may facilitate entry into cells of the central nervous system across species. Seuberlich et al. [3] noted that BoAstV-CH15 was detected in the medulla oblongata, cerebellar cortex, midbrain, and cerebral cortex of infected cattle, mirroring the neural distribution seen in human astrovirus encephalitis cases. Furthermore, the same study identified a second cow, initially thought to be infected with BoAstV-CH13, that tested positive for BoAstV-CH15, suggesting that dual infections or sequential spillover events may occur within bovine populations. The ability of these viruses to persist in neural tissue without causing overt clinical signs in every case, as evidenced by the detection of BoAstV in healthy cattle [1], raises the possibility of subclinical carriers acting as reservoirs for transmission to susceptible species.

From an epidemiological standpoint, the detection of BoAstV in cattle in Central Colombia by Medina et al. [2] underscores the global distribution of this virus and the potential for it to circulate in regions with high human-livestock interface density. Using viral metagenomics, the Colombian study found BoAstV in 19% of fecal samples from dairy cattle, alongside other enteric viruses such as Enterovirus E and Bovine Kobuvirus [2]. Such high prevalence in ostensibly healthy animals increases the likelihood of human exposure through occupational contact, consumption of unpasteurized dairy products, or environmental contamination. The World Health Organization (WHO) and the Food and Agriculture Organization of the United Nations (FAO) have long recognized livestock-associated viruses as a major source of emerging zoonotic diseases, and astroviruses are now included among those with demonstrated neurotropic capacity in humans.

Zoonotic Risk Assessment

Currently, there are no documented cases of BoAstV causing clinical disease in humans. However, the zoonotic risk cannot be dismissed for several reasons. First, human astrovirus strains, particularly those belonging to the HMO clade, have been causally linked to severe encephalitis in immunocompromised patients, and their phylogenetic clustering with BoAstV-CH15 and OvAstV suggests that the capsid protein may engage with similar cellular receptors (such as sialic acid residues or integrins) that are conserved across mammalian species. Second, astroviruses are known to undergo recombination in mixed infections, and cattle harboring both classical enteric BoAstV and neurotropic HMO clade strains could theoretically generate novel chimeric viruses with altered host range. The World Organisation for Animal Health (WOAH) has emphasized the need for enhanced surveillance of astroviruses in livestock, particularly in regions where bovine encephalitis of unknown etiology is common, as these cases may represent sentinel events for the emergence of human pathogenic variants.

The absence of stable passage cell lines for BoAstV, as noted by Zhu et al. [1], has hampered traditional virological studies, including host range determination and receptor binding assays. However, the application of metagenomic next-generation sequencing (mNGS) has revolutionized detection capabilities. Studies such as that by Liu et al. [5] on porcine astrovirus have demonstrated that mNGS can reliably detect astroviruses in fecal material and differentiate between species, providing a blueprint for bovine surveillance. Adapting these methods to bovine clinical samples, as described by Brito et al. [7] for other bovine RNA viruses, could enhance our ability to identify spillover events early. The Centers for Disease Control and Prevention (CDC) has also highlighted the importance of integrating veterinary and human diagnostic networks to detect astroviruses with zoonotic potential before they become widespread.

Diagnostic and Surveillance Challenges

Despite the strong phylogenetic evidence for cross-species transmission, several knowledge gaps remain. No experimental animal model has been established for BoAstV infection [1], which limits our ability to assess tissue tropism, immune response, and transmission dynamics across species. Furthermore, the frequent co-infection of BoAstV with other bovine pathogens, such as bovine viral diarrhea virus, coronavirus, and respiratory bacteria, complicates attribution of disease and obscures its true pathogenic role [1, 6]. From a public health perspective, the absence of routine astrovirus testing in human encephalitis cases, especially those with livestock exposure, means that potential zoonotic spillover could go undiagnosed. The use of targeted NGS assays that incorporate astrovirus primers, as developed by Anis et al. [4] for multiple bovine pathogens, could be expanded to include both human and animal samples in a One Health framework.

In conclusion, the zoonotic implications of BoAstV are rooted in its genomic relationship to neurotropic astroviruses of sheep and humans, its high prevalence in cattle populations globally, and its ability to infect neural tissue without triggering rapid host clearance. While direct evidence of human infection is lacking, the convergence of phylogenetic, epidemiological, and pathological data warrants proactive surveillance efforts. Continued monitoring of bovine encephalitis cases, coupled with mNGS-based characterization of astrovirus diversity in livestock, is essential for early detection of any host-jumping events. The WOAH and the WHO should consider including astroviruses in lists of priority emerging pathogens at the livestock-human interface, and veterinary diagnostic laboratories are encouraged to adopt metagenomic tools that can capture the full genetic breadth of this understudied viral family.

Current Challenges and Future Research Directions for Bovine Astrovirus

The study of Bovine Astrovirus (BoAstV) remains a nascent and profoundly challenging field within veterinary virology, characterized by a landscape of unresolved questions that hinder both a fundamental understanding of the virus and the development of effective control strategies. Despite its first identification in 1978 and its widespread detection across the globe, BoAstV persists as an enigmatic agent whose clinical significance, pathobiology, and ecological dynamics are only beginning to be elucidated [1]. The existing body of research, while invaluable, underscores significant gaps in knowledge that demand urgent and methodical investigation. This section synthesizes the most critical current challenges and delineates the most promising and necessary future research directions, drawing upon the latest insights from metagenomics, comparative virology, and diagnostic innovation.

## Current Challenges in Bovine Astrovirus Research

### Elucidating the Enigmatic Pathogenesis of BoAstV

Perhaps the most formidable challenge in the field is the unresolved pathogenic nature of BoAstV. The virus is consistently identified in both healthy, asymptomatic bovines and those exhibiting clinical disease, ranging from mild gastroenteritis to fatal encephalitis, blurring the line between commensal and pathogen [1, 3]. This ambiguity is compounded by the prevalence of co-infections. BoAstV is frequently detected alongside other enteric and respiratory pathogens, such as Enterovirus E, Bovine Kobuvirus, and Bovine Viral Diarrhea Virus (BVDV), making it exceptionally difficult to attribute causality for specific clinical syndromes [2, 18]. The work by Zhu et al. [1] succinctly captures this dilemma, noting that the pathogenic nature remains "still unclear" due to its prevalence in clinically diverse populations and its near-ubiquitous association with co-infections.

This challenge is further exemplified by the emergence of neurotropic strains. The identification of distinct BoAstV genotypes, such as BoAstV-CH13 and BoAstV-CH15, directly associated with severe non-suppurative encephalitis in cattle, has revolutionized our understanding of the virus's pathogenic potential [3]. Seuberlich et al. [3] demonstrated that these neuroinvasive strains are phylogenetically distinct from classical enteric astroviruses and are a significant cause of encephalitis of unknown etiology in Switzerland. However, even within this neurotropic context, the co-occurrence of two different astrovirus genotypes (CH13 and CH15) in a single encephalitic animal [3] raises further questions about viral synergy, host susceptibility, and the specific triggers that precipitate neuroinvasion from what may be a common enteric infection. A critical gap remains in understanding the host, viral, and environmental factors that determine whether an infection will be subclinical, enteric, or neuroinvasive.

### The Intractable Problem of Viral Isolation and In Vitro Culture

A second, and arguably more fundamental, barrier to progress is the complete lack of a stable, permissive cell culture system for the propagation of BoAstV. As highlighted by Zhu et al. [1], "there are no stable passage cell lines available for the study of BoAstV." This single factor cripples a vast swathe of research avenues. Without a reliable in vitro model, it is impossible to perform standard virological techniques such as:

• Viral neutralization assays to characterize the humoral immune response.
• Plaque assays to quantify infectious viral titers.
• Detailed replication kinetics and life-cycle studies to identify viral entry mechanisms and host-cell interactions.
• High-throughput antiviral screening to identify potential therapeutics.
• Controlled mutagenesis studies to map virulence factors and neurotropic determinants.

The absence of an animal model further compounds this issue, creating a void in our ability to experimentally test Koch's postulates and define the causal role of BoAstV in disease [1]. This dual bottleneck, no in vitro culture and no animal model, fundamentally relegates BoAstV research to descriptive, observational, and correlative studies, precluding the mechanistic experimental research necessary for a mature understanding of its biology.

### Diagnostic and Surveillance Dilemmas

The accurate detection and characterization of BoAstV is fraught with technical hurdles. While metagenomic next-generation sequencing (mNGS) has revolutionized the discovery and surveillance of viruses like BoAstV [2, 4, 5], its application in routine diagnostics is not straightforward. A major challenge lies in the variable sensitivity of metatranscriptomic sequencing, which is heavily influenced by factors such as sequencing depth, the choice of reference genome for mapping, and the quality of the clinical sample [5, 7]. The work by Brito et al. [7] on bovine respiratory viruses demonstrated that detection can fail for samples with high Ct values (indicative of low viral loads) if sequencing depth is insufficient, and that mapping to a divergent reference genome can lead to gross underestimation of viral prevalence. This is acutely relevant for BoAstV, which exhibits immense genetic diversity and for which a "standard" reference genome may not adequately represent the circulating field strains [1, 3]. The finding of Liu et al. [5] that "the selection of reference genomes is crucial for read classification" in astrovirus detection underscores that metagenomic data, while powerful, requires careful optimization and interpretation to avoid false negatives.

Furthermore, the high prevalence of BoAstV in healthy animals [1, 2] creates a significant signal-to-noise problem for surveillance. Determining the baseline "normal" virome and identifying a clinically actionable threshold for BoAstV detection remains a major challenge. A positive mNGS result for BoAstV does not automatically equate to disease causation, and developing diagnostic algorithms that can integrate metagenomic data with clinical and histological findings is a critical unmet need.

### The Unresolved Threat of Cross-Species Transmission

The potential for cross-species transmission of BoAstV is a significant One Health concern that introduces substantial uncertainty. The close phylogenetic relationship between bovine astroviruses, particularly the neurotropic strains, and astroviruses identified in sheep (OvAstV) and human encephalitis cases (HuAstV-PS) [3] immediately raises the specter of zoonotic or reverse-zoonotic potential. The grouping of BoAstV-CH15 with an ovine astrovirus in phylogenetic analyses [3] suggests that the host range for these viruses may be broader than currently appreciated, and that interspecies jumping may be a more frequent evolutionary event than previously thought.

This challenge is intensified by the lack of fundamental knowledge regarding BoAstV receptor usage. Without knowing the host cell receptor, it is impossible to predict with any certainty the species barrier for transmission. As noted by the World Health Organization (WHO) in its broader guidelines on emerging zoonotic diseases, understanding the molecular determinants of host range is the cornerstone of pandemic preparedness. The Food and Agriculture Organization (FAO) also emphasizes that the livestock-wildlife interface is a critical zone for pathogen spillover. The frequent detection of viruses like BoAstV in cattle feces, a primary route of environmental contamination [2], combined with the potential for shared environments between cattle and wildlife or humans, creates a plausible pathway for cross-species transmission that remains entirely unquantified.

## Future Research Directions

The challenges outlined above define a clear and compelling roadmap for future research. The field must pivot from simple descriptive epidemiology to hypothesis-driven, mechanistic investigation.

### Prioritizing the Development of In Vitro and In Vivo Models

The single highest priority for advancing BoAstV research is the development of robust experimental systems. Research efforts should be aggressively directed toward:

1. Cell Culture Systems: Systematic screening of a wide range of primary bovine cell cultures (e.g., intestinal organoids, neural stem cells, fetal kidney cells) and established cell lines, utilizing diverse BoAstV field isolates (both enteric and neurotropic) is essential. The use of reverse genetics to clone a recombinant BoAstV genome, as has been achieved for other astroviruses, could be leveraged to create a reporter virus, facilitating the identification of permissive cell types. Inspiration can be drawn from the methodological approaches used for other fastidious bovine pathogens, such as the diagnostic techniques optimized for Mycobacterium avium subsp. paratuberculosis (MAP) detection [11] and the targeted NGS approaches validated for diagnostic panels [4].
2. Small Animal Models: The establishment of a small animal model, even one that is not permissive for full replication, is critically needed. A mouse model, for instance, could be used to study the early events of neuroinvasion, the host innate immune response, and the role of the blood-brain barrier in restricting or permitting astrovirus entry. Studies of neurotropic astroviruses in mice could provide a powerful system to test hypotheses generated from bovine field data.

### Dissecting Pathogenesis Through Advanced Omics and Comparative Genomics

In the absence of a culture system, the most powerful tools at our disposal are advanced omics technologies.

1. Single-Cell Transcriptomics: Applying single-cell RNA sequencing to brain and intestinal tissue from BoAstV-positive and -negative animals would allow us to identify the exact cell types that are the primary targets of infection in vivo. This would be a game-changer, revealing, for example, whether neurotropic strains specifically infect neurons, glial cells, or microglia, providing direct insights into the mechanism of neuropathology.
2. Comparative Viral Metagenomics: The approach pioneered by Medina et al. [2] must be expanded. Large-scale, longitudinal, controlled studies are needed to systematically compare the entire fecal or nasal virome of clinically healthy animals versus those with specific disease syndromes (e.g., neonatal diarrhea, respiratory disease, encephalitis). This will help to disentangle the specific role of BoAstV from the "noise" of the background virome and identify potential viral co-factors or bacterial microbiome interactions that trigger disease [6].
3. Full-Genome Sequencing and Bioinformatics: The discovery of neurotropic strains [3] highlights the critical importance of surveillance programs that can identify novel, highly divergent variants. Future research must focus on generating complete genomes of BoAstV isolates from diverse geographic regions and clinical presentations. This will allow for robust phylogenetic analyses, the identification of genotype-phenotype associations (e.g., specific capsid sequences linked to neurotropism), and the development of more accurate diagnostic PCR assays that are not blind to divergent strains. The lessons learned from BVDV diagnostics, where sequence divergence from NCBI RefSeq strains led to drastically different metagenomic results [7], are directly applicable here.

### Targeted Investigations into Zoonotic Potential and Host Range

A dedicated, globally-coordinated effort is required to address the cross-species transmission threat. This should include:

1. Receptor Identification: Biochemical studies using recombinant BoAstV capsid proteins or virus-like particles (VLPs) to screen for binding to cells from different species (bovine, ovine, human) are essential. Identifying the cellular receptor is the single most important piece of information for predicting host range.
2. Targeted Sero-Surveillance: Developing specific and sensitive serological assays (e.g., a recombinant protein-based ELISA or a virus neutralization test once a culture system is available) for BoAstV is a priority. Large-scale serological surveys in cattle, but critically also in at-risk human populations (e.g., farm workers, veterinarians, abattoir workers) and in sympatric wildlife species (e.g., deer, sheep, rodents), would provide the most direct evidence for the extent of past and present spillover events. This is fully in line with the World Organisation for Animal Health (WOAH) framework for emerging diseases.

### Refining Diagnostic Algorithms for the Metagenomic Age

To translate metagenomic discoveries into actionable veterinary diagnostics, research must focus on standardization and clinical correlation. As highlighted by Chikh et al. [17] in their evaluation of laboratory diagnostic systems for other bovine diseases, a lack of formalized reporting guidelines and case definitions is a major weakness. For BoAstV, future work should:

1. Establish Standardized Protocols: Develop and validate standardized mNGS protocols specifically optimized for BoAstV detection from different sample types (feces, nasal swabs, brain tissue), including defined thresholds for sequencing depth and read quality [7].
2. Create "Gold Standard" Reference Datasets: Curate a comprehensive, publicly available database of high-quality BoAstV genomes representing the full genetic diversity of the virus, to be used as a mapping reference in bioinformatics pipelines. This would directly counteract the issue of reference-dependence observed by Brito et al. [7].
3. Develop Multi-Pathogen Panels: Leveraging the power of targeted NGS, as demonstrated by Anis et al. [4], the development of a differential diagnostic panel that includes BoAstV alongside other major bovine pathogens (e.g., BVDV, BCoV, Mannheimia haemolytica) would provide a powerful, cost-effective tool for investigating disease outbreaks of unknown etiology, particularly in cases of encephalitis and neonatal diarrhea. Such syndromic surveillance is highly recommended by the FAO and CDC for detecting emerging disease threats.

References

[1] Zhu Q, Li B, Sun D. Bovine Astrovirus, A Comprehensive Review. Viruses. 2022. DOI: https://doi.org/10.3390/v14061217

[2] Medina J, Castañeda S, Páez-Triana L, Camargo M, García-Corredor D, Gómez M, et al.. High prevalence of Enterovirus E, Bovine Kobuvirus, and Astrovirus revealed by viral metagenomics in fecal samples from cattle in Central Colombia.. Infection, Genetics and Evolution. 2023. DOI: https://doi.org/10.1016/j.meegid.2023.105543

[3] Seuberlich T, Wüthrich D, Selimovic-Hamza S, Drögemüller C, Oevermann A, Bruggmann R, et al.. Identification of a second encephalitis-associated astrovirus in cattle. Emerging Microbes and Infections. 2016. DOI: https://doi.org/10.1038/emi.2016.5

[4] Anis E, Hawkins I, Ilha M, Woldemeskel M, Saliki J, Wilkes R. Evaluation of Targeted Next-Generation Sequencing for Detection of Bovine Pathogens in Clinical Samples. Journal of Clinical Microbiology. 2018. DOI: https://doi.org/10.1128/JCM.00399-18

[5] Liu L, Hakhverdyan M, Wallgren P, Vanneste K, Fu Q, Lucas P, et al.. An interlaboratory proficiency test using metagenomic sequencing as a diagnostic tool for the detection of RNA viruses in swine fecal material. Microbiology spectrum. 2024. DOI: https://doi.org/10.1128/spectrum.04208-23

[6] Johnston D, Earley B, Cormican P, Murray G, Kenny D, Waters S, et al.. Illumina MiSeq 16S amplicon sequence analysis of bovine respiratory disease associated bacteria in lung and mediastinal lymph node tissue. BMC Veterinary Research. 2017. DOI: https://doi.org/10.1186/s12917-017-1035-2

[7] Brito B, Frost M, Webster J, To J, Kirkland PD. Quantifying the impact of sequencing depth and reference genome choice on metatranscriptomic detection of four bovine RNA viruses.. Research in Veterinary Science. 2026. DOI: https://doi.org/10.1016/j.rvsc.2026.106125

[8] Shome R, Natesan K, Kalleshamurthy T, Yadav C, Sahay S, Skariah S, et al.. Management of bovine brucellosis in organized dairy herds through the identification of risk factors: A cross-sectional study from Karnataka, India. Veterinary World. 2023. DOI: https://doi.org/10.14202/vetworld.2023.1122-1130

[9] McRae G, Leek D, Meija J, Shurmer B, Lehotay S, Polzer J, et al.. Production and certification of BOTS-1: bovine muscle–certified reference material for incurred veterinary drug residues. Analytical and Bioanalytical Chemistry. 2023. DOI: https://doi.org/10.1007/s00216-023-04794-5

[10] Priyantha M, Fernando P, Liyanagunawardana N, Samarakoon N, Dissanayake D, Wijemuni MI, et al.. Status of Bovine Brucellosis in the Submitted Samples at Veterinary Research Institute from 2019 to 2021. Wayamba Journal of Animal Science. 2021. DOI: https://doi.org/10.4038/wjas.v13i0.27

[11] Grant IR, Sevilla I, Molina E, Martinez BR, Lorente-Leal V, Thibault-Poisson VC, et al.. Evaluation of the reproducibility and performance characteristics of the Phagomagnetic separation-qPCR assay for rapidly detecting viable Mycobacterium avium subsp. paratuberculosis in bovine milk and feces. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1677096

[12] Mamanova S, Bashenova E, Kaimoldina S, Nissanova R, Akshalova P, Kirpichenko V, et al.. OPTIMIZATION OF THE MANUFACTURING CONDITIONS OF AN AGID TEST SYSTEM FOR THE DIAGNOSIS OF BOVINE LEUKEMIA. Eurasian journal of applied biotechnology. 2025. DOI: https://doi.org/10.11134/btp.3.2025.11

[13] Graham D, More S, O'Sullivan P, Lane E, Barrett D, Lozano J, et al.. The Irish Programme to Eradicate Bovine Viral Diarrhoea Virus, Organization, Challenges, and Progress. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.674557

[14] Bashenova E, Kirpichenko V, Nissanova R, Mamanova S, Dyusenov SM, Lesov B, et al.. DIAGNOSIS OF BOVINE VIRAL DIARRHEA: THE IMPORTANCE OF STANDARDIZING CONTROL SERA FOR INTERLABORATORY COMPARISONS. Ġylym ža̋ne bìlìm. 2025. DOI: https://doi.org/10.52578/2305-9397-2025-3-1-237-248

[15] Wood PL, Erol E. Construction of a Bacterial Lipidomics Analytical Platform: Pilot Validation with Bovine Paratuberculosis Serum. Metabolites. 2023. DOI: https://doi.org/10.3390/metabo13070809

[16] Gao S, Du J, Tian Z, Niu Q, Huang D, Wang J, et al.. A SYBR green I–based quantitative RT-PCR assay for bovine ephemeral fever virus and its utility for evaluating viral kinetics in cattle. Journal of Veterinary Diagnostic Investigation. 2019. DOI: https://doi.org/10.1177/1040638719895460

[17] Chikh M, Ngwa-Mbot D, Morignat E, Mémeteau S, Amat J. OASIS evaluation of the French laboratory diagnostic surveillance system: right people, right techniques but imperfect use. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1419034

[18] Simanova I, Alekseyenkova SV, Yurov K. Molecular-genetic analysis of bovine herpesvirus-5 (BoHV-5) in the milk of cows in farms of Vologda region. IOP Conference Series: Earth and Environment. 2020. DOI: https://doi.org/10.1088/1755-1315/548/7/072042

[19] Bronsvoort B, Koterwas B, Land F, Handel I, Tucker J, Morgan K, et al.. Comparison of a Flow Assay for Brucellosis Antibodies with the Reference cELISA Test in West African Bos indicus. PLoS ONE. 2009. DOI: https://doi.org/10.1371/journal.pone.0005221